scispace - formally typeset
D

Diana Alecsandru

Researcher at Hospital Clínico San Carlos

Publications -  8
Citations -  113

Diana Alecsandru is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Recurrent miscarriage & Single-nucleotide polymorphism. The author has an hindex of 4, co-authored 8 publications receiving 46 citations.

Papers
More filters
Journal ArticleDOI

A review of the pathophysiology of recurrent implantation failure.

TL;DR: In this paper, the authors discuss factors including the maternal immune system, genetics of the embryo and parents, anatomic factors, hematologic factors, reproductive tract microbiome, and endocrine milieu, which factors into embryo and endometrial synchrony.
Journal ArticleDOI

Parental human leukocyte antigen-C allotypes are predictive of live birth rate and risk of poor placentation in assisted reproductive treatment

TL;DR: Elective SET improves the reproductive outcomes compared with DET, and the selection of HLA-C1 over Hla-C2 donors could have a positive impact on the LBR in KIR AA patients, according to maternal killer cell immunoglobulin-like receptor genes.
Journal ArticleDOI

Interleukin-10 haplotypes in Celiac Disease in the Spanish population

TL;DR: The data suggest that the IL-10 alteration seen in patients may be more consequence than cause of the disease, and no significant associations after Bonferroni correction were observed in the SNPs or any of the microsatellites.
Journal ArticleDOI

Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients.

TL;DR: It seems that the development of articular manifestations in ulcerative colitis patients appears to be influenced by some genetic factor(s) present in some major histocompatibility complex haplotypes.
Journal ArticleDOI

E. coli Multiresistant Meningitis after Transrectal Prostate Biopsy

TL;DR: The case of acute meningitis by multiresistant E. coli after transrectal prostate biopsy presented demonstrates that antibiotic prevention with ciprofloxacin is not absolutely risk free, especially when it is performed in patients who will not benefit from that biopsy.